Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

CONSORT 2025 statement: updated guideline for reporting randomized trials: a Korean translation.

Hopewell S. et al, (2025), Ewha Med J, 48

Reducing inequalities through greater diversity in clinical trials – As important for medical devices as for drugs and therapeutics

Roope LSJ. et al, (2025), Contemporary Clinical Trials Communications, 45

Clustering of Multimorbidity and Social Care Needs: 10-year all-cause mortality in a cohort study of more than 7 million people

Islam N. et al, (2025)

SPIRIT 2025 explanation and elaboration: updated guideline for protocols of randomised trials

Hróbjartsson A. et al, (2025), BMJ (Clinical research ed.), 389

CONSORT 2025 statement: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), Lancet

CONSORT 2025 statement: Updated guideline for reporting randomised trials

Hopewell S. et al, (2025), PLoS Medicine, 22

SPIRIT 2025 statement: Updated guideline for protocols of randomised trials

Chan AW. et al, (2025), PLoS Medicine, 22

The association of loneliness and social isolation with multimorbidity over 14 years in older adults in England: A population-based cohort study

Hounkpatin H. et al, (2025), Archives of Gerontology and Geriatrics, 131

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study

Dennis JM. et al, (2025), Lancet, 405, 701 - 714

Implementation of evidence-based foot screening in people with diabetes: A scoping review

Houghton JM. et al, (2025), Journal of Diabetes and its Complications, 39

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes

Sammons E. et al, (2025), BMJ Open, 15

Challenges and barriers to physician decision-making for prescribing and deprescribing among patients with multimorbidity in eastern China's primary care settings: A qualitative study

Zhou X. et al, (2025), BMJ Open, 15

The Digital Health Competencies in Medical Education Framework: An International Consensus Statement Based on a Delphi Study

Car J. et al, (2025), JAMA network open, 8

A five-drug class model using routinely available clinical features to optimise prescribing in type 2 diabetes: a prediction model development and validation study

Dennis JM. et al, (2025), LANCET, 405, 701 - 714

CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials

Hopewell S. et al, (2025), BMJ

CONSORT 2025 statement: updated guideline for reporting randomised trials

Hopewell S. et al, (2025), BMJ

CONSORT 2025 statement: updated guideline for reporting randomized trials

Hopewell S. et al, (2025), Nature Medicine

CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials

Hopewell S. et al, (2025), JAMA

Evaluating prediction of short-term tolerability of five type 2 diabetes drug classes using routine clinical features: UK population-based study

Cardoso P. et al, (2025), Diabetes Obesity and Metabolism

Experiences of Using a Digital Text Messaging Intervention to Support Oral Medication Adherence for People Living With Type 2 Diabetes: Qualitative Process Evaluation

Newhouse N. et al, (2025), Journal of Medical Internet Research, 27

Load More

1
2
3
4
5
6
7
...
»